超越边界:利用边界结果得分的纵向暴露-反应模型,在加速药物开发范式中为决策提供信息
Yeamin Huh1, Jessica Wojciechowski2, Vivek S Purohit2
1Worldwide Development, Research and Medical, Pfizer Inc, 280 Shennecossett Rd, Groton, CT, 06340, USA. yeamin.huh@pfizer.com.
Clinical pharmacokinetics
|February 15, 2024
概括
基于模型的药物开发 (MIDD) 使用连续边界结果 (CBO) 建模支持阿洛佩西亚带状脱发症里特利西丁的加速开发. 模拟表明,暂时的治疗中断长达6周不会显著影响疗效.
科学领域:
- 药学指标 (Pharmacometrics) 是一个指标.
- 量化药理学 量化药理学
- 药物开发科学 药物开发科学
背景情况:
- 基于模型的药物开发 (MIDD) 通过对数据进行上下文化和帮助决策来加速治疗的可用性.
- 这项研究以Ritlecitinib的联合2b期和单一关键试验中的MIDD为例,这是一种JAK3 / TEC家族激酶抑制剂.
研究的目的:
- 描述一个MIDD应用在药物开发中的例子.
- 使用纵向暴露-反应 (ER) 建模来评估利西提尼布在白发症患者的疗效.
主要方法:
- 使用纵向暴露-反应 (ER) 建模来描述利西提尼的疗效.
- 脱发症严重程度工具 (SALT) 评分,连续边界结果 (CBO),作为主要疗效终点.
- 在SALT得分间隔内的平均药物度是暴露度量.
主要成果:
- 该CBO模型准确地描绘了纵向SALT得分和边界数据频率.
- 测试的剂量位于上升的ER区域,加载剂量会影响发病,但不会影响长期益处.
- 疾病严重程度是唯一影响疗效的共同变量.
- 基于模型的模拟表明,暂时的治疗中断 (≤6周) 对疗效的影响最小.
结论:
- CBO建模方法和模拟支持单一的关键试验策略,以加速Ritelecitinib的开发.
- 这种方法适用于使用边界有效度表的其他适应症.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Dose-Response Relationship: Overview
3.1K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.1K
Longitudinal Research
12.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.0K
Analysis of Population Pharmacokinetic Data
256
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
256
Longitudinal Studies
160
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
160
Mechanistic Models: Compartment Models in Individual and Population Analysis
41
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
41


